SG155209A1 - Process for preparing renin inhibitors - Google Patents

Process for preparing renin inhibitors

Info

Publication number
SG155209A1
SG155209A1 SG200905377-8A SG2009053778A SG155209A1 SG 155209 A1 SG155209 A1 SG 155209A1 SG 2009053778 A SG2009053778 A SG 2009053778A SG 155209 A1 SG155209 A1 SG 155209A1
Authority
SG
Singapore
Prior art keywords
renin inhibitors
preparing renin
preparing
inhibitors
renin
Prior art date
Application number
SG200905377-8A
Other languages
English (en)
Inventor
Stuart John Mickel
Gottfried Sedelmeier
Hans Hirt
Frank Schaefer
Michael Foulkes
Walter Prikoszovich
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SG155209A1 publication Critical patent/SG155209A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SG200905377-8A 2005-06-08 2006-06-06 Process for preparing renin inhibitors SG155209A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0511686.8A GB0511686D0 (en) 2005-06-08 2005-06-08 Organic compounds

Publications (1)

Publication Number Publication Date
SG155209A1 true SG155209A1 (en) 2009-09-30

Family

ID=34835327

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200905377-8A SG155209A1 (en) 2005-06-08 2006-06-06 Process for preparing renin inhibitors

Country Status (24)

Country Link
US (2) US7767831B2 (fr)
EP (2) EP1896411A2 (fr)
JP (2) JP2008542415A (fr)
KR (1) KR20080014011A (fr)
CN (1) CN101193860B (fr)
AR (1) AR054374A1 (fr)
AU (1) AU2006256938B2 (fr)
BR (1) BRPI0611919A2 (fr)
CA (1) CA2608575A1 (fr)
EC (1) ECSP077986A (fr)
GB (1) GB0511686D0 (fr)
GT (1) GT200600208A (fr)
IL (1) IL187004A0 (fr)
MA (1) MA29563B1 (fr)
MX (1) MX2007015418A (fr)
NO (1) NO20080080L (fr)
NZ (2) NZ562889A (fr)
PE (2) PE20070075A1 (fr)
RU (1) RU2418785C2 (fr)
SG (1) SG155209A1 (fr)
TN (1) TNSN07465A1 (fr)
TW (1) TW200716544A (fr)
WO (1) WO2006131304A2 (fr)
ZA (1) ZA200709076B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0521083D0 (en) * 2005-10-17 2005-11-23 Novartis Ag Organic compounds
DE102007049039A1 (de) 2007-10-11 2009-04-16 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung
EP2062874B1 (fr) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Procédé et intermédiaires pour la préparation d'aliskiren
CN101952242B (zh) 2007-12-24 2015-05-20 DPx控股有限公司 肾素抑制剂的汇集合成和其中有用的中间产物
SI2189442T1 (sl) 2008-11-20 2015-03-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek in intermediati za pripravo aliskirena
MX347956B (es) * 2009-08-11 2017-05-16 Massachusetts Inst Technology Abertura de anillo de lactonas y lactamas.
US8203005B2 (en) 2009-10-29 2012-06-19 Carbo Design Llc Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren
EP2523934A1 (fr) * 2010-02-10 2012-11-21 Ratiopharm GmbH Sels d'aliskirène
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren
CN111423325A (zh) * 2020-04-26 2020-07-17 江苏凯迪恩医药科技有限公司 基于蒽醌类药物的双醋瑞因合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570108A (en) * 1982-07-06 1986-02-11 Stroede Aake Protection device for electrical incandescent lamps
US5606078A (en) 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
US5659065A (en) 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
CA2121898A1 (fr) * 1994-04-21 1995-10-22 Stephen Hanessian Synthese de prototypes d'inhibiteurs de la renine
IT1292426B1 (it) * 1997-06-27 1999-02-08 Nicox Sa Sali nitrati di ace-inibitori
JP2005231999A (ja) * 2000-03-08 2005-09-02 Banyu Pharmaceut Co Ltd カルバペネム誘導体の製造方法
WO2002002508A1 (fr) 2000-07-05 2002-01-10 Speedel Pharma Ag Procede de preparation d'amide d'octanoyl substitues
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
ES2274847T3 (es) * 2000-12-14 2007-06-01 Speedel Pharma Ag Proceso para preparar ariloctanoil-amidas.
GB0419361D0 (en) * 2004-08-31 2004-10-06 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
GT200600208A (es) 2007-03-28
BRPI0611919A2 (pt) 2010-10-05
RU2418785C2 (ru) 2011-05-20
AR054374A1 (es) 2007-06-20
CN101193860A (zh) 2008-06-04
EP2080754A2 (fr) 2009-07-22
TNSN07465A1 (en) 2009-03-17
US20080207921A1 (en) 2008-08-28
NO20080080L (no) 2008-01-04
TW200716544A (en) 2007-05-01
WO2006131304A3 (fr) 2007-07-19
MA29563B1 (fr) 2008-06-02
JP2008542415A (ja) 2008-11-27
AU2006256938B2 (en) 2009-12-17
CA2608575A1 (fr) 2006-12-14
AU2006256938A1 (en) 2006-12-14
NZ562889A (en) 2011-11-25
MX2007015418A (es) 2008-02-21
GB0511686D0 (en) 2005-07-13
NZ591010A (en) 2012-06-29
RU2007148226A (ru) 2009-07-20
KR20080014011A (ko) 2008-02-13
JP2013028607A (ja) 2013-02-07
IL187004A0 (en) 2008-02-09
EP2080754A3 (fr) 2010-06-02
ECSP077986A (es) 2008-01-23
WO2006131304A2 (fr) 2006-12-14
ZA200709076B (en) 2008-10-29
US20100274027A1 (en) 2010-10-28
EP1896411A2 (fr) 2008-03-12
CN101193860B (zh) 2013-01-02
US7767831B2 (en) 2010-08-03
PE20070075A1 (es) 2007-03-16
PE20091359A1 (es) 2009-10-13

Similar Documents

Publication Publication Date Title
AP2577A (en) Process for preparing diaminophenothiazinium compounds
IL194508A0 (en) Process for synthesizing organoelemental compounds
HRP20100166T4 (en) Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
IL199124A (en) A process for preparing fluoromethyl-converted heterocyclic compounds
IL187004A0 (en) Process for preparing renin inhibitors
PL2074108T6 (pl) Inhibitory reniny
IL186117A0 (en) Substituted piperidines as renin inhibitors
PL2213654T3 (pl) Sposób wytwarzania pochodnych 2-amino-5-bromobenzamidu
PT2084128E (pt) Processo para a preparação de isocianatos
IL185769A0 (en) Heterocyclic-substituted alkanamides useful as renin inhibitors
IL197099A0 (en) Process for preparing polybrominated compounds
ZA200708208B (en) Process for producing cyclopropylphenol derivative
IL184342A0 (en) Process for preparing ??-amino-??-hydroxycarboxamides
ZA200706260B (en) Process for preparing protected amiidines
ZA200608083B (en) Process for preparing 5-methyl-2-furfural
ZA200808419B (en) Primary amines as renin inhibitors
IL192702A0 (en) Process for producing 5-alkoxy-4-hydroxymethylpyrazole compound
TWI372145B (en) Process for preparing alkylanilides
EP1751123A4 (fr) Processus pour préparer de l'irbésartan
GB0416694D0 (en) Process for preparing microcrystals
IL198686A0 (en) Process for preparing cinacalcet
IL189574A0 (en) Process for preparing 1-substituted-5-acylimidazole compounds
IL195262A0 (en) Process for preparing hydroxylpatite
IL188273A0 (en) Process for preparing benzimidazole compounds
EP1988172A4 (fr) Procede de production de (meth)acrylamide